Acadia's FDA Breakthrough Designation For Pimavanserin Draws Mixed Response
October 05, 2017 at 14:20 PM EDT
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough ...